Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer Breadcrumbs UL Home Research Publications Year of Publication 2008 Journal Clinical Cancer Research DOI 10.1158/1078-0432.CCR-07-1760
